Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026)

Neumora Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at $30000.0 for Q1 2026.

• In Q1 2026, Tax Provisions fell 71.43% year-over-year to $30000.0; the TTM figure through Mar 2026 stood at $55000.0 (down 80.57% YoY), while the FY2025 annual figure was $130000.0, down 26.97% from the prior year.
• Tax Provisions was $30000.0 for Q1 2026 at Neumora Therapeutics, up from $25000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $125000.0 in Q2 2024 to a low of $25000.0 in Q2 2025.
• Historically, Tax Provisions has averaged $67600.0 across 3 years, with a median of $53000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Tax Provisions slumped 80.0% in 2025, then plunged 71.43% in 2026.
• A 3-year view of Tax Provisions shows it stood at $53000.0 in 2024, then plunged by 52.83% to $25000.0 in 2025, then gained by 20.0% to $30000.0 in 2026.
• The last three Tax Provisions figures came in at $30000.0 (Q1 2026), $25000.0 (Q2 2025), and $105000.0 (Q1 2025), per Business Quant data.